Loading…
Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹34.5 LQualified Make: Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED
Model: Mefloquine Tablets IP 250MG | Make: Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED
Model: Mefloquine Tablets IP 250MG | ₹34.5 L | L1 | Qualified MII |
| 2 | Disqualified Make: Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED
Model: Mefloquine Tablets IP 250MG 0 0 NIGAHI NAWANAGAR SINGRAULI MADHYA PRADESH 486884 | SINGRAULI | MADHYA PRADESH | 486884 | Make: Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED
Model: Mefloquine Tablets IP 250MG | - | - | Disqualified MII |
| 3 | Disqualified Make: Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED
Model: Mefloquine Tablets IP 250MG 01 INDIRA MARKETING SHANTIVILLA FIST FLOOR BEHIND J B APARMENT GALI TIKRAP TIKRAPARA BILASPUR CHHATTISGARH 495001 | BILASPUR | CHHATTISGARH | 495001 | Make: Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED
Model: Mefloquine Tablets IP 250MG | - | - | Disqualified MII |
Tender Value
Refer Docs
EMD Value
₹90,000
Closing Date
14 Nov 2024, 1:00 pmClosed
Mefloquine Tablet (Q2)
7012905
GEM/2024/B/5496416
Two Packet Bid
Mefloquine Tablet
75 days
Chhattisgarh; Raipur
Total value wise evaluation
PRODUCT
8 documents required · 8 mandatory
3 yrs
₹3
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Mefloquine Tablet (Q2) | AJAY KUMAR SINGH 493441,Group Centre CRPF Raipur Vill-Bhilai, Tehsil-Arang, Distt-Raipur, Chhattisgarh - 493441 | 75,000 | 75 days |
₹90,000
19 Nov 2024
4 Nov 2024
14 Nov 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7012905.pdf
GEM_BID
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .